Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on August 23, 2004

Circulation. 2004
Published online before print August 23, 2004, doi: 10.1161/01.CIR.0000140764.15398.F3
A more recent version of this article appeared on September 7, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/10/1313    most recent
01.CIR.0000140764.15398.F3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, W.-J.
Right arrow Articles by Pang, J.-H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.-J.
Right arrow Articles by Pang, J.-H. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats
Hazardous Substances DB
*LIOTHYRONINE
*PROPYL THIOURACIL
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Smooth muscle proliferation and differentiation
Right arrow Lipid and lipoprotein metabolism

Submitted on October 13, 2003
Revised on May 13, 2004
Accepted on May 19, 2004

Protective Effect of Propylthiouracil Independent of Its Hypothyroid Effect on Atherogenesis in Cholesterol-Fed Rabbits. PTEN Induction and Inhibition of Vascular Smooth Muscle Cell Proliferation and Migration

Wei-Jan Chen MD, PhD, Kwang-Huei Lin PhD, Ying-Ju Lai , Su-Hui Yang , and Jong-Hwei S. Pang PhD*

From the First Cardiovascular Division, Chang Gung Memorial Hospital (W.-J.C., Y.-J.L., S.-H.Y.), and Department of Biochemistry (K.-H.L.) and Graduate Institute of Clinical Medical Sciences (J.-H.S.P.), Chang Gung University, Tao-Yuan, Taiwan.

* To whom correspondence should be addressed. E-mail: jonghwei{at}mail.cgu.edu.tw.

Background--Propylthiouracil (PTU) is used to treat hyperthyroid patients by its hypothyroid effect. PTU also is found to have potent antioxidant and immunosuppressive effects. These findings suggest that PTU may play a role in the prevention of atherosclerosis.

Methods and Results--This study evaluates the effect of PTU on atherosclerotic change in rabbits fed a high-cholesterol diet. The pronounced atherosclerotic lesions in the aortas of rabbits fed a 2% cholesterol diet for 12 weeks were significantly attenuated by the concurrent addition of 0.1% PTU to the drinking water. However, exogenous supplementation of thyroid hormone in hypothyroid PTU-treated rabbits did not abrogate the protective effect of PTU on atherogenesis. Immunohistochemical analysis showed that PTU administration apparently reduced the intimal smooth muscle cell/macrophage ratio in the atherosclerotic plaques of rabbits fed a 2% cholesterol diet. In vitro, the addition of PTU to the medium of cultured rat vascular smooth muscle cells led to a dose-dependent inhibition of cell proliferation and migration. Furthermore, this study confirmed that PTU dose-dependently increased expression of PTEN, a tumor suppressor gene known to be involved in the coordinate inhibition of VSMC proliferation and migration.

Conclusions--This study demonstrated that PTU inhibited the development of atherosclerosis through a thyroid-independent mechanism that may be explained, at least in part, by the ability of PTU to inhibit vascular smooth muscle cell proliferation and migration. Furthermore, PTEN induction, via disruption of the phosphatidylinsitol 3-kinase-mediated pathway, plays a crucial role in mediating the inhibitory action on vascular smooth muscle cell proliferation and migration.


Key words: atherosclerosis • propylthiouracil • muscle, smooth, vascular • tumor suppressor proteins




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. Selvendiran, M. L. Kuppusamy, A. Bratasz, L. Tong, B. K. Rivera, C. Rink, C. K. Sen, T. Kalai, K. Hideg, and P. Kuppusamy
Inhibition of Vascular Smooth-Muscle Cell Proliferation and Arterial Restenosis by HO-3867, a Novel Synthetic Curcuminoid, through Up-Regulation of PTEN Expression
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 959 - 966.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Nemenoff, P. A. Simpson, S. B. Furgeson, N. Kaplan-Albuquerque, J. Crossno, P. J. Garl, J. Cooper, and M. C.M. Weiser-Evans
Targeted Deletion of PTEN in Smooth Muscle Cells Results in Vascular Remodeling and Recruitment of Progenitor Cells Through Induction of Stromal Cell-Derived Factor-1{alpha}
Circ. Res., May 9, 2008; 102(9): 1036 - 1045.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G Sener, L Kabasakal, B M Atasoy, C Erzik, A Velioglu-Ogunc, S Cetinel, G Contuk, N Gedik, and B C Yegen
Propylthiouracil-induced hypothyroidism protects ionizing radiation-induced multiple organ damage in rats.
J. Endocrinol., May 1, 2006; 189(2): 257 - 269.
[Abstract] [Full Text] [PDF]